Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stoke Therapeutics (STOK), Embecta Corporation (EMBC...

Wall Street Analysts Are Bullish on Top Healthcare Picks

An announcement from Embecta Corporation ( ($EMBC) ) is now available. On March 19, 2026, Embecta announced a definitive agreement to acquire priva...

Current Quarter	$0.42	Next Quarter	$NA
Current Year	$2.82	Next Year	$2.86
QoQ Growth	NaN%	YoY Growth	+1.4%
3Y EPS CAGR	-25.2%	Target Price	$16.67
Consensus	Buy	Upside	+87.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EMBC	$8.90	+0.74%	230.96K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EMBC	$8.90	+0.7%	230.96K
3
4
5
6

EMBC

EMBC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Embecta Corp. Data in Excel

Get Embecta Corp. Data in Excel